New Zealand markets closed
  • NZX 50

    11,267.39
    +60.46 (+0.54%)
     
  • NZD/USD

    0.6410
    +0.0027 (+0.43%)
     
  • NZD/EUR

    0.6062
    +0.0037 (+0.62%)
     
  • ALL ORDS

    7,391.00
    +87.70 (+1.20%)
     
  • ASX 200

    7,145.60
    +81.10 (+1.15%)
     
  • OIL

    110.35
    +0.46 (+0.42%)
     
  • GOLD

    1,845.10
    +3.90 (+0.21%)
     
  • NASDAQ

    11,835.62
    -40.01 (-0.34%)
     
  • FTSE

    7,389.98
    +87.24 (+1.19%)
     
  • Dow Jones

    31,261.90
    +8.77 (+0.03%)
     
  • DAX

    13,981.91
    +99.61 (+0.72%)
     
  • Hang Seng

    20,717.24
    +596.56 (+2.96%)
     
  • NIKKEI 225

    26,739.03
    +336.19 (+1.27%)
     
  • NZD/JPY

    81.9320
    +0.4160 (+0.51%)
     

Outlook on the Veterinary Antimicrobial Susceptibility Testing Global Market to 2028 - Featuring BioMerieux, Thermo Fisher Scientific and Bruker Among Others

·7-min read

Dublin, Jan. 21, 2022 (GLOBE NEWSWIRE) -- The "Veterinary Antimicrobial Susceptibility Testing Market Size, Share & Trends Analysis Report By Animal Type (Livestock Animals, Companion Animals), By Product, By End Use, By Region, And Segment Forecasts, 2021 - 2028" report has been added to ResearchAndMarkets.com's offering.

The global veterinary antimicrobial susceptibility testing market size is expected to reach USD 52.78 billion by 2028, according to a new report by the publisher. The market is expected to expand at a CAGR of 5.1% from 2021 to 2028. The key factors fueling the market growth include growing demand for livestock products and increasing government initiatives.

Government initiatives mandating safe healthcare practices for livestock and companion animals are fueling the growth of the market. Several governments worldwide are focused on protecting animals and humans from antibiotics resistance. In addition, efforts are being taken to increase awareness about the reduction of usage of antimicrobials in food animals. The WHO is collaborating with the World Organization for Animal Health (OIE), Food and Agriculture Organization (FAO), national ministries of health, World Bank, and UNSIC to take major actions regarding antimicrobial resistance, which is further propelling the market growth.

The growing demand for animal products, such as milk, chicken, eggs, and meat, is encouraging farmers to adopt an antibiotics policy for their animals to gain higher profitability. Due to the rising urbanization, consumers are becoming more aware of the nutritious value of animal protein. The demand for healthy, sustainable, and high-quality meat products that have comparatively few or no antimicrobials is also increasing rapidly. Thus, the need for healthy breeding of animals is increasing, which is expected to fuel the growth of the market.

Veterinary Antimicrobial Susceptibility Testing Market Report Highlights

  • By animal type, livestock animals dominated the market in 2020 due to the stringent regulatory guidelines regarding antimicrobial usage in livestock animals. Cattle accounted for over 38.0% share in 2020 due to the increasing demand for milk and the growing expenditure on livestock

  • The companion animal type segment is estimated to grow notably due to the increasing concerns over the transmission of resistance from companion to humans

  • Based on product, AST automated instruments accounted for the largest share of over 41.0% in 2020 due to its increasing adoption and higher cost. Disks and plates are expected to witness significant growth over the forecast period owing to their increased usage in labs and research institutes

  • In terms of end-use, in 2020, the veterinary reference lab segment held the largest share owing to its patient footfall and increased number of tests

  • Asia Pacific held the largest revenue share in 2020 owing to its growing livestock population and increased government initiatives

Key Topics Covered:

Chapter 1 Methodology and Scope

Chapter 2 Executive Summary

Chapter 3 Veterinary Antimicrobial susceptibility testing Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Penetration& Growth Prospect Mapping, 2020
3.3 Veterinary Antimicrobial susceptibility testing Market Dynamics
3.3.1 Market driver analysis
3.3.2 Market restraint analysis
3.3.3.Market opportunity analysis
3.3.4. Market challenge analysis
3.4 Veterinary Antimicrobial susceptibility testing Market Analysis Tools: Porters
3.4.1 Supplier Power
3.4.2. Buyer Power
3.4.3. Substitution Threat
3.4.4. Threat of New Entrants
3.4.5. Competitive Rivalry
3.5 Veterinary Antimicrobial susceptibility testing Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
3.5.1 Political/Legal Landscape
3.5.2 Economic Landscape
3.5.3 Social Landscape
3.5.4 Technology Landscape
3.6 Livestock and Companion Animal Population, by Country

Chapter 4 COVID-19 Impact Analysis
4.1 COVID-19 Prevalence Analysis
4.2. Impact of COVID-19 on Veterinary Antimicrobial susceptibility testing Market

Chapter 5 Veterinary Antimicrobial susceptibility testing Market: Segment Analysis, By Animal Type, 2016 - 2028 (USD Million)
5.1 Animal Type Market Share Analysis, 2020 & 2028
5.2 Veterinary Antimicrobial susceptibility testing market, by Animal Type, 2016 to 2028
5.3 Livestock Animals
5.3.1 Livestock Animals market, 2016 - 2028 (USD Million)
5.3.2. Cattle
5.3.2.1 Cattle market, 2016 - 2028 (USD Million)
5.3.3 Poultry
5.3.3.1 Poultry market, 2016 - 2028 (USD Million)
5.3.4 Pigs
5.3.4.1 Pigs market, 2016 - 2028 (USD Million)
5.3.5 Others
5.3.5.1 Others market, 2016 - 2028 (USD Million)
5.4 Companion Animals
5.4.1 Companion Animals market, 2016 - 2028 (USD Million)
5.4.2.Cats
5.4.2.1 Cats market, 2016 - 2028 (USD Million)
5.4.3 Dogs
5.4.3.1 Dogs market, 2016 - 2028 (USD Million)
5.4.4 Horses
5.4.4.1 Horses market, 2016 - 2028 (USD Million)
5.4.5 Others
5.4.5.1 Others market, 2016 - 2028 (USD Million)

Chapter 6 Veterinary Antimicrobial susceptibility testing Market: Segment Analysis, By Product, 2016 - 2028 (USD Million)
6.1 Product Market Share Analysis, 2020 & 2028
6.2 Veterinary Antimicrobial susceptibility testing market, by Product, 2016 to 2028
6.3 Disks & Plates
6.3.1 Disks & Plates market, 2016 - 2028 (USD Million)
6.4 Culture Media
6.4.1 Culture Media market, 2016 - 2028 (USD Million)
6.5 Accessories & Consumables
6.5.1 Accessories & Consumables market, 2016 - 2028 (USD Million)
6.6 Automated AST Instruments
6.6.1 Automated AST Instruments market, 2016 - 2028 (USD Million)

Chapter 7 Veterinary Antimicrobial susceptibility testing Market: Segment Analysis, By End Use, 2016 - 2028 (USD Million)
7.1 End-use Market Share Analysis, 2020 & 2028
7.2 Veterinary Antimicrobial susceptibility testing Market, by End-Use, 2016 to 2028
7.3 Veterinary Reference Lab
7.3.1 Veterinary Reference Lab market, 2016 - 2028 (USD Million)
7.4 Veterinary Research Institutes
7.4.1 Veterinary Research Institutes market, 2016 - 2028 (USD million)
7.5 Others
7.5.1 Others market, 2016 - 2028 (USD million)

Chapter 8 Veterinary Antimicrobial susceptibility testing Market: Regional Market Analysis 2016 - 2028 (USD Million)

Chapter 9 Veterinary Antimicrobial susceptibility testing Market - Competitive Analysis
9.1 Market Participant Categorization
9.1.1. Company Market Position Analysis,
9.1.2 Heat map analysis
9.1.3. Synergy Analysis: Major Deals & Strategic Alliances
9.1.4. Market Leaders
9.1.5. Innovators
9.2. List of Key Companies

Chapter 10 Veterinary Antimicrobial susceptibility testing Market - Company Profiles
10.1 BioMerieux SA
10.1.1 Company overview
10.1.2 FINANCIAL PERFORMANCE
10.1.3 Product benchmarking
10.1.4 Strategic initiatives
10.2 Becton, Dickinson and Company
10.2.1 Company overview
10.2.2 Financial performance
10.2.3 Product benchmarking
10.2.4 Strategic initiatives
10.3 Synbiosis
10.3.1 Company overview
10.3.2 Financial performance
10.3.3 Product benchmarking
10.3.4 Strategic initiatives
10.4 Thermo Fisher Scientific
10.4.1 Company overview
10.4.2 Financial performance
10.4.3 Product benchmarking
10.4.4 Strategic initiatives
10.5 Bruker Corporation
10.5.1 Company overview
10.5.2 Financial performance
10.5.3 Product benchmarking
10.5.4 Strategic initiatives
10.6 Danaher Corporation
10.6.1 Company overview
10.6.2 Financial performance
10.6.3 Product benchmarking
10.6.4 Strategic initiatives
10.7 Condalab
10.7.1 Company overview
10.7.2 Financial performance
10.7.3 Product benchmarking
10.7.4 Strategic initiatives
10.8 Bioguard Corporation
10.8.1 Company overview
10.8.2 Financial performance
10.8.3 Product benchmarking
10.8.4 Strategic initiatives
10.9 Liofilchem S.r.l.
10.9.1 Company overview
10.9.2 Financial performance
10.9.3 Product benchmarking
10.9.4 Strategic initiatives
10.10 HiMedia Laboratories
10.10.1 Company overview
10.10.2 Financial performance
10.10.3 Product benchmarking
10.10.4 Strategic initiatives
10.11 Bio-Rad Laboratories
10.11.1 Company overview
10.11.2 Financial performance
10.11.3 Product benchmarking
10.11.4 Strategic initiatives
10.12 Neogen Corporation
10.12.1 Company overview
10.12.2 Financial performance
10.12.3 Product benchmarking
10.12.4 Strategic initiatives

For more information about this report visit https://www.researchandmarkets.com/r/sviaw6

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting